Market Research

Hydroxyzine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets, Capsules, Injection, Syrup), By Indication Type (Histamine-mediated pruritus, Utricaria, Atopic contact dermatitis), By Region and Comp

Best Price Guarantee Length Publisher Published Date SKU
from $4,900 188 Pages TechSci Research September, 2024 TCSI19139964
Best Price Guarantee
Price from $4,900
Length 188 Pages
Publisher TechSci Research
Published Date September, 2024
SKU TCSI19139964

Hydroxyzine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets, Capsules, Injection, Syrup), By Indication Type (Histamine-mediated pruritus, Utricaria, Atopic contact dermatitis), By Region and Competition, 2019-2029F


evolving healthcare needs related to mental well-being on a global scale.

Ongoing Research for Novel Formulations

The Global Hydroxyzine Market is witnessing a surge in research and development activities focused on creating novel formulations of hydroxyzine. Pharmaceutical companies are actively engaged in ongoing research to enhance the drug's therapeutic efficacy, patient compliance, and overall market appeal. These efforts aim to address various challenges and optimize the clinical utility of hydroxyzine in diverse therapeutic contexts. One area of exploration involves the development of sustained-release formulations. Creating formulations with prolonged release characteristics could potentially provide a more consistent and extended therapeutic effect, reducing the frequency of administration and improving patient adherence to treatment regimens. Combination therapies are also under consideration in research initiatives. By combining hydroxyzine with other complementary compounds, researchers aim to enhance its anxiolytic properties, broaden its spectrum of efficacy, or minimize potential side effects. These novel combinations could offer innovative treatment options for healthcare providers and more tailored solutions for patients. The research is delving into optimizing the bioavailability and pharmacokinetics of hydroxyzine to improve its overall performance. Innovations in drug delivery systems, such as nanoparticles or liposomal formulations, are being explored to enhance the drug's delivery to target tissues and organs, potentially maximizing therapeutic outcomes. The ongoing research for novel formulations reflects the commitment of pharmaceutical researchers to address existing limitations and unlock new therapeutic potentials for hydroxyzine. These endeavors contribute to the dynamic evolution of the Global Hydroxyzine Market, paving the way for innovative products that cater to the evolving healthcare landscape and the diverse needs of patients.

Segmental Insights

Dosage Form Insights

1. Based on dosage form, tablets segment dominated the Global Hydroxyzine Market in 2023. This is ascribed due to its convenience, ease of administration, and dosage accuracy. Hydroxyzine, commonly prescribed for anxiety and allergic conditions, is widely formulated as oral tablets. Tablets offer a standardized dosage, simplifying medication management for both patients and healthcare providers. The solid dosage form ensures stability, easy storage, and a longer shelf life. The patient preference for tablets, coupled with pharmaceutical manufacturers' focus on tablet formulations, contributes to the dominance of this segment in the market, meeting the demand for a widely accepted and practical delivery method for hydroxyzine.

Regional Insights

North America dominated in the Global Hydroxyzine Market, driven by the region benefits from a well-established healthcare infrastructure and a high prevalence of conditions like anxiety and allergies, for which Hydroxyzine is commonly prescribed. North America is home to major pharmaceutical companies with a strong focus on research and development, contributing to the innovation and availability of Hydroxyzine products. Rigorous regulatory standards ensure the safety and efficacy of pharmaceuticals, boosting consumer confidence. A a robust healthcare system and high healthcare expenditure enhance accessibility to Hydroxyzine medications. These factors collectively position North America as the dominant market for Hydroxyzine on the global stage.

Recent Development
  • In December 2022, Brillpharma (Ireland) received marketing authorization from HPRA for their Hydroxyzine hydrochloride 25mg film-coated tablets. This approval signifies the regulatory endorsement of Brillpharma's product, indicating compliance with standards set by the Health Products Regulatory Authority. The granted authorization enhances Brillpharma's ability to bring this specific formulation of hydroxyzine to the market, contributing to pharmaceutical options available for various therapeutic applications.
Key Market Players
  • R-Biopharm AG
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • GSK plc
  • bioMerieux S.A.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare AG
  • AbbVie Inc.
  • Pfizer Inc.
Report Scope:

In this report, the Global Hydroxyzine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Hydroxyzine Market, By Dosage Form:
  • Tablets
  • Capsules
  • Injection
  • Syrup
  • Hydroxyzine Market, By Indication Type:
  • Histamine-mediated pruritus
  • Utricaria
  • Atopic contact dermatitis
  • Hydroxyzine Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hydroxyzine Market.

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Hydroxyzine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Dosage Form (Tablets, Capsules, Injection, Syrup)
5.2.2. By Indication Type (Histamine-mediated pruritus, Utricaria, Atopic contact dermatitis)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
5.3.1. By Dosage Form
5.3.2. By Indication Type
5.3.3. By Region
6. Asia Pacific Hydroxyzine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Dosage Form
6.2.2. By Indication Type
6.2.3. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Hydroxyzine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Dosage Form
6.3.1.2.2. By Indication Type
6.3.2. India Hydroxyzine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Dosage Form
6.3.2.2.2. By Indication Type
6.3.3. Australia Hydroxyzine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Dosage Form
6.3.3.2.2. By Indication Type
6.3.4. Japan Hydroxyzine Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Dosage Form
6.3.4.2.2. By Indication Type
6.3.5. South Korea Hydroxyzine Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Dosage Form
6.3.5.2.2. By Indication Type
7. Europe Hydroxyzine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Dosage Form
7.2.2. By Indication Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Hydroxyzine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Dosage Form
7.3.1.2.2. By Indication Type
7.3.2. Germany Hydroxyzine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Dosage Form
7.3.2.2.2. By Indication Type
7.3.3. Spain Hydroxyzine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Dosage Form
7.3.3.2.2. By Indication Type
7.3.4. Italy Hydroxyzine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Dosage Form
7.3.4.2.2. By Indication Type
7.3.5. United Kingdom Hydroxyzine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Dosage Form
7.3.5.2.2. By Indication Type
8. North America Hydroxyzine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Dosage Form
8.2.2. By Indication Type
8.2.3. By Country
8.3. North America: Country Analysis
8.3.1. United States Hydroxyzine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Dosage Form
8.3.1.2.2. By Indication Type
8.3.2. Mexico Hydroxyzine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Dosage Form
8.3.2.2.2. By Indication Type
8.3.3. Canada Hydroxyzine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Dosage Form
8.3.3.2.2. By Indication Type
9. South America Hydroxyzine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Dosage Form
9.2.2. By Indication Type
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Hydroxyzine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Dosage Form
9.3.1.2.2. By Indication Type
9.3.2. Argentina Hydroxyzine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Dosage Form
9.3.2.2.2. By Indication Type
9.3.3. Colombia Hydroxyzine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Dosage Form
9.3.3.2.2. By Indication Type
10. Middle East and Africa Hydroxyzine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Dosage Form
10.2.2. By Indication Type
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Hydroxyzine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Dosage Form
10.3.1.2.2. By Indication Type
10.3.2. Saudi Arabia Hydroxyzine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Dosage Form
10.3.2.2.2. By Indication Type
10.3.3. UAE Hydroxyzine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Dosage Form
10.3.3.2.2. By Indication Type
10.3.4. Egypt Hydroxyzine Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Dosage Form
10.3.4.2.2. By Indication Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Hydroxyzine Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. R-Biopharm AG
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (In case of listed)
15.1.5. Recent Developments
15.1.6. SWOT Analysis
15.2. Teva Pharmaceutical Industries Ltd
15.3. Sun Pharmaceutical Industries Ltd
15.4. GSK plc
15.5. bioMerieux S.A.
15.6. Danaher Corporation
15.7. Thermo Fisher Scientific, Inc
15.8. Siemens Healthcare AG
15.9. AbbVie Inc.
15.10. Pfizer Inc.
16. Strategic Recommendations
17. About Us & Disclaimer

$4,900
$5,900
$8,900

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings